Technical advances in NK cell-based cellular immunotherapy

Technical advances in NK cell-based cellular immunotherapy

Natural killer (NK) cells represent a promising future for tumor immunotherapy because of their unique biological functions and characteristics. This review focuses on technical advances in NK cell-based cellular immunotherapy and summarizes the developments of recent years in cell sources, genetic...

Full description

Bibliographic Details
Main Authors:	Fang Fang, Wei Wang, Minhua Chen, Zhigang Tian, Weihua Xiao
Format:	Article
Language:	English
Published:	China Anti-Cancer Association 2019-12-01
Series:	Cancer Biology & Medicine
Subjects:	natural killer cell immunotherapy adoptive cell transfer genetic modification
Online Access:	http://www.cancerbiomed.org/index.php/cocr/article/view/1506

Similar Items

CAR-NK cells for cancer immunotherapy: recent advances and future directions
by: Tianye Li, et al.
Published: (2024-02-01)

Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
by: Ying Gong, et al.
Published: (2021-05-01)

NK Cell-Based Immunotherapy and Therapeutic Perspective in Gliomas
by: Changqing Pan, et al.
Published: (2021-10-01)

Natural Killer cell recognition of melanoma: new clues for a more effective immunotherapy
by: Raquel eTarazona, et al.
Published: (2016-01-01)

Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
by: Kevin O. McNerney, et al.
Published: (2020-05-01)

The Advances and Challenges of NK Cell-Based Cancer Immunotherapy
by: Synat Kang, et al.
Published: (2021-02-01)

Tumor-priming converts NK cells to memory-like NK cells
by: Marina Pal, et al.
Published: (2017-06-01)

Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire
by: Raffaella Meazza, et al.
Published: (2023-02-01)

The role of NK and NKT cells in the pathogenesis and improvement of multiple sclerosis following disease‐modifying therapies
by: Alireza Ahmadi, et al.
Published: (2022-01-01)

Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy
by: Linxuan Miao, et al.
Published: (2024-03-01)

NK cell mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
by: Wei eWang, et al.
Published: (2015-07-01)

Directed Differentiation of Mobilized Hematopoietic Stem and Progenitor Cells into Functional NK Cells with Enhanced Antitumor Activity
by: Pranav Oberoi, et al.
Published: (2020-03-01)

Enhancing a Natural Killer: Modification of NK Cells for Cancer Immunotherapy
by: Rasa Islam, et al.
Published: (2021-04-01)

Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
by: Xiao Wang, et al.
Published: (2022-11-01)

Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer
by: Philippa R. Kennedy, et al.
Published: (2022-04-01)

Comparative assessment of autologous and allogeneic iNKT cell transfer in iNKT cell-based immunotherapy
by: Mariko Takami, et al.
Published: (2024-08-01)

Antitumor Immunity: Role of NK Cells and Extracellular Vesicles in Cancer Immunotherapy
by: Angelina E. Prokopeva, et al.
Published: (2023-12-01)

Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
by: Congcong Zhang, et al.
Published: (2017-05-01)

PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival
by: Jeremiah L. Oyer, et al.
Published: (2024-04-01)

From CAR-T Cells to CAR-NK Cells: A Developing Immunotherapy Method for Hematological Malignancies
by: Hui Lu, et al.
Published: (2021-08-01)

Optimising NK cell metabolism to increase the efficacy of cancer immunotherapy
by: Chloe Choi, et al.
Published: (2021-06-01)

Targeting NK cells for anti-cancer immunotherapy: clinical and pre-clinical approaches
by: Sebastian eCarotta, et al.
Published: (2016-04-01)

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
by: John P. Veluchamy, et al.
Published: (2017-05-01)

Innovative Strategies to Improve the Clinical Application of NK Cell-Based Immunotherapy
by: Mubin Tarannum, et al.
Published: (2022-03-01)

Efficiency of ADOPTIVE immunotherapy for melanoma: a case REPORT
by: E. V. Abakushina, et al.
Published: (2016-11-01)

Efficacy of Cytokine-Induced Killer Cell Immunotherapy for Patients With Pathologically Pure Glioblastoma
by: Myung-Hoon Han, et al.
Published: (2022-04-01)

Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide
by: Serena Pellegatta, et al.
Published: (2018-04-01)

NK cell based immunotherapy against oral squamous cell carcinoma
by: Ying Zhang, et al.
Published: (2024-08-01)

Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters
by: Sarah Parisi, et al.
Published: (2022-01-01)

The War Is on: The Immune System against Glioblastoma—How Can NK Cells Drive This Battle?
by: Lucas Henrique Rodrigues da Silva, et al.
Published: (2022-02-01)

Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
by: Weilei Hu, et al.
Published: (2019-05-01)

Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial
by: Robert J. Canter, et al.
Published: (2017-12-01)

Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy
by: Cai Zhang, et al.
Published: (2020-06-01)

Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
by: Qiaofei Liu, et al.
Published: (2023-02-01)

The Promise of Personalized TCR-Based Cellular Immunotherapy for Cancer Patients
by: Marion Arnaud, et al.
Published: (2021-07-01)

Metabolic Reprogramming of NK Cells by Black Phosphorus Quantum Dots Potentiates Cancer Immunotherapy
by: Lizhen He, et al.
Published: (2023-03-01)

Natural killer cell memory: challenges and opportunities for cancer immunotherapy
by: Yuhua Qu, et al.
Published: (2024-12-01)

Cellular immunotherapy in multiple myeloma
by: Manh-Cuong Vo, et al.
Published: (2019-09-01)

NK cell transfer overcomes resistance to PD-(L)1 therapy in aged mice
by: Junlei Hou, et al.
Published: (2024-05-01)

Current Advances in γδ T Cell-Based Tumor Immunotherapy
by: Elena Lo Presti, et al.
Published: (2017-10-01)